Legal status by country
Is Supaglutide legal?
Written by Aaron CuhaReviewed Sep 2026
How Supaglutide is classified in the United States, United Kingdom, Australia and Canada, side by side. Each country has its own page with a direct answer, the regulator's approval status and what the classification means in practice.
All four countries, side by side
| Attribute | United States · FDA | United Kingdom · MHRA | Australia · TGA | Canada · Health Canada |
|---|---|---|---|---|
| Status | Not approved | Not approved | Not approved | Not approved |
| Classification | Not approved; research use only | Not licensed | Not approved | Not approved |
| Note | No FDA approval. Approved in mainland China since January 2025 as efsubaglutide alfa for type 2 diabetes. | No MHRA licence. The entire clinical programme was conducted in China. | Not registered with the TGA. | No Health Canada submission located. |
US FDA status: Not approved in the United States. Approved by China's National Medical Products Administration in January 2025 for glycaemic control in adults with type 2 diabetes, under the name efsubaglutide alfa, and included in China's national reimbursement drug list. Not approved for weight management anywhere.. Reviewed Sep 2026.
Related compounds
General information current as of Sep 2026, not legal advice. Classifications change; confirm with the regulator or a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships.